Skip to main content

Table 1 Characteristics of the study population

From: Association between iron metabolism and non-alcoholic fatty liver disease: results from the National Health and Nutrition Examination Survey (NHANES 2017–2018) and a controlled animal study

Variable

Overall (n = 5483)

Non-NAFLD (n = 3553)

NAFLD (n = 1930)

P-value

Age, years

44.425 ± 0.622

41.660 ± 0.551

50.490 ± 0.723

< 0.001

Sex, %

0.006

 Male

2705 (49.3%)

1851 (52.1%)

854 (44.2%)

 

 Female

2778 (50.7%)

1702 (47.9%)

1076 (55.8%)

 

Race, %

0.237

 Mexican American

810 (14.8%)

497 (14.0%)

313 (16.2%)

 

 Other hispanic

511 (9.3%)

329 (9.3%)

182 (9.4%)

 

 Non-hispanic black

1216 (22.2%)

801 (22.5%)

415 (21.5%)

 

 Non-hispanic white

1868 (34.1%)

1218 (34.3%)

650 (33.7%)

 

 Other race

1078 (19.7%)

708 (19.9%)

370 (19.2%)

 

Family PIR

2.999 ± 0.062

3.032 ± 0.060

2.926 ± 0.083

0.102

Education level, %

0.691

 Less than high school

1632 (29.8%)

1046 (29.4%)

586 (30.4%)

 

 High school

1212 (22.1%)

787 (22.2%)

425 (22.0%)

 

 More than high school

2639 (48.1%)

1720 (48.4%)

919 (47.6%)

 

Marital status, %

< 0.001

 Having a partner

3031 (55.3%)

1912 (53.8%)

1119 (58.0%)

 

 No partner

1054 (19.2%)

614 (17.3%)

440 (22.8%)

 

 Unmarried

1398 (25.5%)

1027 (28.9%)

371 (19.2%)

 

Hypertension, %

< 0.001

 No

3342 (61.0%)

2361 (66.5%)

978 (50.7%)

 

 Yes

2141 (39.0%)

1189 (33.5%)

952 (49.3%)

 

DM, %

< 0.001

 No

4491 (81.9%)

3097 (87.2%)

1394 (72.2%)

 

 Yes

992 (12.8%)

456 (12.8%)

536 (27.8%)

 

Smoker, %

0.083

 No

3328 (60.7%)

2141 (60.3%)

1187 (61.5%)

 

 Former

1157 (21.1%)

697 (19.6%)

460 (23.8%)

 

 Now

998 (18.2%)

715 (20.1%)

283 (14.7%)

 

Alcohol user, %

< 0.001

 No

873 (15.9%)

354 (10.0%)

519 (26.9%)

 

 Mild

2233 (40.7%)

1509 (42.5%)

724 (37.5%)

 

 Moderate

1045 (19.1%)

741 (20.9%)

304 (15.8%)

 

 Heavy

1332 (24.3%)

949 (26.7%)

383 (19.8%)

 

CHD, %

< 0.001

 No

5291 (96.5%)

3457 (97.3%)

1834 (95.0%)

 

 Yes

192 (3.5%)

96 (2.7%)

96 (5.0%)

 

CHF, %

0.007

 No

5360 (97.8%)

3493 (98.3%)

1867 (96.7%)

 

 Yes

123 (2.2%)

60 (1.7%)

63 (3.3%)

 

Angina pectoris, %

0.023

 No

5356 (97.7%)

3488 (98.2%)

1868 (96.8%)

 

 Yes

127 (2.3%)

65 (1.8%)

62 (3.2%)

 

Heart attack, %

0.033

 No

5278 (96.3%)

3439 (96.8%)

1839 (95.3%)

 

 Yes

205 (3.7%)

114 (3.2%)

91 (4.7%)

 

Stroke, %

0.017

 No

5274 (96.2%)

3434 (96.7%)

1840 (95.3%)

 

 Yes

209 (3.8%)

119 (3.3%)

90 (4.7%)

 

PA, %

0.015

 No

2855 (52.1%)

1790 (50.4%)

1065 (55.2%)

 

 Moderate

1211 (22.1%)

785 (22.1%)

426 (22.1%)

 

 Both

1164 (21.2%)

800 (22.5%)

364 (18.9%)

 

 Vigorous

253 (4.6%)

178 (5.0%)

75 (3.9%)

 

 Mean energy

2074.407 ± 21.096

2106.648 ± 28.210

2003.693 ± 22.084

0.011

Intake (kcal/day)

 Protein intake, g

79.987 ± 1.152

81.589 ± 1.519

76.474 ± 1.306

0.020

 Folic acid intake, mcg

175.012 ± 3.764

180.048 ± 4.461

163.965 ± 4.359

0.008

 Vitamin B12 intake, mcg

4.757 ± 0.084

4.880 ± 0.116

4.487 ± 0.099

0.028

 Vitamin C intake, mg

73.632 ± 1.368

75.895 ± 1.777

68.670 ± 1.151

0.002

 Iron intake, mg

14.124 ± 0.196

14.347 ± 0.260

13.635 ± 0.212

0.046

 BMI, kg/m2

29.138 ± 0.243

27.900 ± 0.246

31.854 ± 0.349

 < 0.001

 Waist circumference, cm

98.776 ± 0.636

95.438 ± 0.681

106.097 ± 0.798

 < 0.001

 Hb, g/dL

14.207 ± 0.059

14.304 ± 0.061

13.994 ± 0.073

 < 0.001

 Hs-CRP, mg/L

3.588 ± 0.145

2.990 ± 0.137

4.899 ± 0.332

 < 0.001

 HbA1c, %

5.629 ± 0.015

5.523 ± 0.017

5.861 ± 0.026

 < 0.001

 ALT, U/L

22.515 ± 0.378

24.199 ± 0.474

18.823 ± 0.440

 < 0.001

 AST, U/L

22.094 ± 0.264

23.372 ± 0.384

19.290 ± 0.305

 < 0.001

 GGT, U/L

28.258 ± 0.502

29.288 ± 0.700

25.999 ± 0.797

0.013

 TC, mg/dL

185.497 ± 1.588

184.524 ± 1.722

187.630 ± 1.521

0.015

 TG, mg/dL

136.928 ± 3.177

129.096 ± 4.015

154.106 ± 2.392

 < 0.001

 HDL-C, mmol/L

1.381 ± 0.012

1.414 ± 0.014

1.309 ± 0.011

 < 0.001

 BUN, mg/dL

14.589 ± 0.168

14.444 ± 0.175

14.909 ± 0.180

0.003

 UA, mg/dL

5.344 ± 0.035

5.284 ± 0.048

5.475 ± 0.036

0.008

 Scr, mg/dL

0.862 ± 0.006

0.858 ± 0.007

0.871 ± 0.008

0.147

 eGFR, ml/min/1.73m2

98.810 ± 0.853

101.082 ± 0.806

93.826 ± 0.969

 < 0.001

 uACR

34.535 ± 3.264

31.025 ± 3.231

42.232 ± 5.562

0.053

 SI, µg/dL

89.073 ± 1.107

92.688 ± 1.348

81.144 ± 1.441

 < 0.001

 SF, µg/L

138.120 ± 3.320

140.087 ± 4.352

133.804 ± 4.726

0.342

 TSAT, %

27.489 ± 0.291

28.671 ± 0.397

24.897 ± 0.378

 < 0.001

 sTfR, mg/L

3.211 ± 0.047

3.114 ± 0.049

3.423 ± 0.070

 < 0.001

  1. NAFLD, Non-alcoholic fatty liver disease; family PIR, family poverty income ratio; DM, diabetes mellitus; BMI, body mass index, PA, physical activity; Hb, hemoglobin; hs-CRP, high-sensitivity C-reactive protein; HbA1c, glycosylated hemoglobin; ALT, alanine aminotransferase; AST, aspartate aminotransferase; GGT, gamma-glutamyl transpeptidase; TC, total cholesterol; TG, triglycerides; HDL-C, high- density lipoprotein-cholesterol, BUN, blood urea nitrogen; UA, uric acid; Scr, serum creatinine; eGFR, estimated glomerular filtration rate; uACR, urinary albumin creatinine ratio; SI, serum iron; SF, serum ferritin; TSAT, Transferrin saturation; sTfR, soluble transferrin receptor